Evidence map›Paper›PMID 32515814›Full record

Observational studyJAMA2020

Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.

Benjamin M Smith, Miranda Kirby, Eric A Hoffman, Richard A Kronmal, Shawn D Aaron, Norrina B Allen, Alain Bertoni, Harvey O Coxson, Chris Cooper, David J Couper and 19 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in JAMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 188 citations in OpenAlex.

  1. Dysanapsis and the Spirometric Response to Inhaled Bronchodilators.American journal of respiratory and critical care medicine · 2021
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Early dysanapsis in experimental bronchopulmonary dysplasia: implications for lifelong lung disease.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Opportunistic Screening on Chest CT, From theAJR. American journal of roentgenology · 2026
    Review
  13. Pre-COPD: Impact on prevention, detection, and treatment.Presse medicale (Paris, France : 1983) · 2026
    Review
  14. Article
  15. The Developmental Origins of Asthma and COPD.Annual review of physiology · 2026
    Review
  16. Long-term pulmonary outcomes in BPD throughout the life-course.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  17. HighERJ open research · 2026
    Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 2 countries.

Benjamin M SmithDepartment of Medicine, Columbia University Medical Center, New York, New York.
Miranda KirbyDepartment of Physics, Ryerson University, Toronto, Ontario, Canada.
Eric A HoffmanDepartment of Radiology, University of Iowa, Iowa City.
Richard A KronmalDepartment of Biostatistics, University of Washington, Seattle.
Shawn D AaronDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Norrina B AllenDepartment of Medicine, Northwestern University, Chicago, Illinois.
Alain BertoniDepartment of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Harvey O CoxsonDepartment of Radiology, University of British Columbia, Vancouver, Canada.
Chris CooperDepartment of Medicine, University of California, Los Angeles.
David J CouperDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill.
Gerard CrinerDepartment of Medicine, Temple University, Philadelphia, Pennsylvania.
Mark T DransfieldDepartment of Medicine, University of Alabama at Birmingham, Birmingham.
MeiLan K HanDepartment of Medicine, University of Michigan, Ann Arbor.
Nadia N HanselDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
David R JacobsDivision of Epidemiology and Community Health School of Public Health, University of Minnesota, Minneapolis.
Joel D KaufmanDepartment of Epidemiology, University of Washington, Seattle.
Ching-Long LinDepartment of Mechanical Engineering, University of Iowa, Iowa City.
Ani ManichaikulDepartment of Public Health Sciences, University of Virginia, Charlottesville.
Fernando J MartinezDepartment of Medicine, Cornell University, New York, New York.
Erin D MichosDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
Elizabeth C OelsnerDepartment of Medicine, Columbia University Medical Center, New York, New York.
Robert PaineDepartment of Medicine, University of Utah, Salt Lake City.
Karol E WatsonDepartment of Medicine, University of California, Los Angeles.
Andrea BenedettiDepartment of Medicine, McGill University, Montreal, Quebec, Canada.
Wan C TanDepartment of Medicine, University of British Columbia, Vancouver, Canada.
Jean BourbeauDepartment of Medicine, McGill University, Montreal, Quebec, Canada.
Prescott G WoodruffDepartment of Medicine, University of California, San Francisco.
R Graham BarrDepartment of Medicine, Columbia University Medical Center, New York, New York.
MESA Lung, CanCOLD, and SPIROMICS Investigators
Columbia University Irving Medical Center · USMcGill University · CAUniversity of British Columbia · CAUniversity of California, Los Angeles · USUniversity of Iowa · USUniversity of Washington · USCornell University · USJohns Hopkins Medicine · USJohns Hopkins University · USNorthwestern University · USTemple University · USToronto Metropolitan University · CAUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Michigan · USUniversity of Minnesota · USUniversity of North Carolina at Chapel Hill · USUniversity of Ottawa · CAUniversity of Utah · USUniversity of Virginia · US

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)R01HL093081 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2008 to 2026
$17.2M
SPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2M
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICSR01HL121270 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARR, R GRAHAM, LAINE, ANDREW FRANCIS · 2014 to 2022
$5.6M
Mentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2M
Hypercoagulability and Chronic Lung Disease in Older AdultsK23HL130627 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OELSNER, ELIZABETH · 2016 to 2019
$686k
NHLBI NIH HHS K23 HL130627NHLBI NIH HHS K24 HL137013NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01 HL093081NHLBI NIH HHS R01 HL121270NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

Importance: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD), yet much of COPD risk remains unexplained. Objective: To determine whether dysanapsis, a mismatch of airway tree caliber to lung size, assessed by computed tomography (CT), is associated with incident COPD among older adults and lung function decline in COPD. Design, Setting, and Participants: A retrospective cohort study of 2 community-based samples: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, which involved 2531 participants (6 US sites, 2010-2018) and the Canadian Cohort of Obstructive Lung Disease (CanCOLD), which involved 1272 participants (9 Canadian sites, 2010-2018), and a case-control study of COPD: the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), which involved 2726 participants (12 US sites, 2011-2016). Exposures: Dysanapsis was quantified on CT as the geometric mean of airway lumen diameters measured at 19 standard anatomic locations divided by the cube root of lung volume (airway to lung ratio). Main Outcomes and Measures: Primary outcome was COPD defined by postbronchodilator ratio of forced expired volume in the first second to vital capacity (FEV1:FVC) less than 0.70 with respiratory symptoms. Secondary outcome was longitudinal lung function. All analyses were adjusted for demographics and standard COPD risk factors (primary and secondhand tobacco smoke exposures, occupational and environmental pollutants, and asthma). Results: In the MESA Lung sample (mean [SD] age, 69 years [9 years]; 1334 women [52.7%]), 237 of 2531 participants (9.4%) had prevalent COPD, the mean (SD) airway to lung ratio was 0.033 (0.004), and the mean (SD) FEV1 decline was -33 mL/y (31 mL/y). Of 2294 MESA Lung participants without prevalent COPD, 98 (4.3%) had incident COPD at a median of 6.2 years. Compared with participants in the highest quartile of airway to lung ratio, those in the lowest had a significantly higher COPD incidence (9.8 vs 1.2 cases per 1000 person-years; rate ratio [RR], 8.12; 95% CI, 3.81 to 17.27; rate difference, 8.6 cases per 1000 person-years; 95% CI, 7.1 to 9.2; P < .001) but no significant difference in FEV1 decline (-31 vs -33 mL/y; difference, 2 mL/y; 95% CI, -2 to 5; P = .30). Among CanCOLD participants (mean [SD] age, 67 years [10 years]; 564 women [44.3%]), 113 of 752 (15.0%) had incident COPD at a median of 3.1 years and the mean (SD) FEV1 decline was -36 mL/y (75 mL/y). The COPD incidence in the lowest airway to lung quartile was significantly higher than in the highest quartile (80.6 vs 24.2 cases per 1000 person-years; RR, 3.33; 95% CI, 1.89 to 5.85; rate difference, 56.4 cases per 1000 person-years; 95% CI, 38.0 to 66.8; P<.001), but the FEV1 decline did not differ significantly (-34 vs -36 mL/y; difference, 1 mL/y; 95% CI, -15 to 16; P=.97). Among 1206 SPIROMICS participants (mean [SD] age, 65 years [8 years]; 542 women [44.9%]) with COPD who were followed up for a median 2.1 years, those in the lowest airway to lung ratio quartile had a mean FEV1 decline of -37 mL/y (15 mL/y), which did not differ significantly from the decline in MESA Lung participants (P = .98), whereas those in highest quartile had significantly faster decline than participants in MESA Lung (-55 mL/y [16 mL/y ]; difference, -17 mL/y; 95% CI, -32 to -3; P = .004). Conclusions and Relevance: Among older adults, dysanapsis was significantly associated with COPD, with lower airway tree caliber relative to lung size associated with greater COPD risk. Dysanapsis appears to be a risk factor associated with COPD.

Indexed as

Forced Expiratory VolumeVital CapacityAgedFemaleHumansLungMalePulmonary Disease, Chronic ObstructiveRetrospective StudiesRisk FactorsSmokingSpirometryTomography, X-Ray Computed

Identifiers

PMID32515814
PMCPMC7284296
OpenAlexW3033045524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.